al-101
Generic: Apomorphine
al-101: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Oncotelic Therapeutics, Inc. (OTLC) | — |
Get deeper analysis on al-101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis